Simply Wall St.
Retail investors in Prelude Therapeutics Incorporated (NASDAQ:PRLD) are its biggest bettors, and their bets paid off as stock gained 12% last week
📊
AI Sentiment
Positive
7/10
Latest updates and market news for PRLD
AI Sentiment
Positive
7/10
Share this news page